04/15/2024
4:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
8:35 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:50 PM | Bausch Christoph Lawrence (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:55 PM | SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sullivan Eddie Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:40 PM | Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:02 AM | RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
| Form SC 13G | |
|
02/14/2024
5:28 AM | Radcliffe Capital Management, L.P. (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
6:53 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
3:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 424B5 | |
01/25/2024
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:21 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
8:00 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
8:34 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form DEF 14A | |
12/08/2023
4:26 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form PRE 14A | |
12/08/2023
7:00 AM | SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sullivan Eddie Joe (Reporting)
Sullivan Eddie Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
3:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
| Form SC 13G | |
11/30/2023
4:00 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
7:00 AM | Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
6:40 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form EFFECT | |
11/22/2023
3:45 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | Ellias Helen K. (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
3:45 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form S-3/A | |
11/15/2023
8:10 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4/A | |
11/15/2023
3:30 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 4/A | |
11/14/2023
6:00 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:50 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/03/2023
3:40 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/27/2023
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
4:30 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
4:33 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
3:30 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form PRE 14A | |
10/16/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
| Form SC 13G | |
10/16/2023
3:08 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/10/2023
3:24 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form EFFECT | |
08/21/2023
3:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/21/2023
7:25 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:23 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
07/31/2023
3:43 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:19 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form POS AM | |
07/03/2023
12:20 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:05 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form RW | |
06/21/2023
7:50 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:53 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
8:29 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form DEF 14A | |
05/17/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form EFFECT | |
05/09/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
| Form EFFECT | |
